Clinical use of antimicrobial regional limb perfusion in horses : 174 cases (1999–2009)

Show simple item record

dc.contributor.author Rubio-Martinez, Luis M.
dc.contributor.author Elmas, Colette R.
dc.contributor.author Black, Belinda
dc.contributor.author Monteith, Gabrielle
dc.date.accessioned 2013-02-07T09:02:56Z
dc.date.available 2013-02-07T09:02:56Z
dc.date.issued 2012-12
dc.description.abstract OBJECTIVE—To describe the clinical use of regional limb perfusion with antimicrobials (A-RLP), complications, and outcome in a large series of patients. DESIGN—Retrospective case series. ANIMALS—174 horses. PROCEDURES—Medical records of horses treated with A-RLP between 1999 and 2009 were reviewed. Signalment, primary complaint, horse use, etiology, duration of clinical signs, previous treatment, structures involved, concurrent conditions, A-RLP characteristics, additional treatments, complications, and outcome were recorded. At long-term follow-up, 2 outcomes were investigated: survival rate and return to previous use at the same or higher level. Univariate and multivariate logistic regression analyses were conducted. RESULTS—Group 1 (96 horses) included septic synovitis. Group 2 (50 horses) included extrasynovial lacerations (23 horses) and fresh, minimally contaminated intrasynovial lacerations without evidence of established synovial infection (27 horses). Group 3 (28 horses) included miscellaneous other conditions. Only minor complications were reported in 12.26% of horses that received IV (n = 155) and 33% of horses that received intraosseous (27) A-RLP. Horses with septic synovitis had a lower survival rate (53.43%) than did horses with lacerations (91.89%). Within group 2, no significant differences in short- or long-term outcomes were found between horses with extrasynovial and fresh, minimally contaminated intrasynovial lacerations. For the horses returning to previous use, 80% of horses with septic synovitis and 72.72% of horses with lacerations were performing at the same or higher level at the time of follow-up. CONCLUSIONS AND CLINICAL RELEVANCE—The results of the present study indicated that A-RLP is a safe technique with minimal adverse effects. The IV route presented fewer complications than intraosseous injection. Horses with infection of synovial structures had a lower survival rate than did those with acute, minimally contaminated intrasynovial lacerations. The latter had a similar prognosis for horses with extrasynovial lacerations treated with A-RLP. en
dc.description.librarian am2013 en
dc.description.librarian mn2013
dc.description.uri http://avmajournals.avma.org/loi/javma en
dc.identifier.citation Rubio-Martinez, LM, Elmas, CR, Black, B & Monteith, G 2012, 'Clinical use of antimicrobial regional limb perfusion in horses : 174 cases (1999–2009)', JAVMA_Journal of the American Veterinary Medical Association, vol. 241, no. 12, pp. 1650-1658. en
dc.identifier.issn 003-1488
dc.identifier.uri http://hdl.handle.net/2263/20966
dc.language.iso en en
dc.publisher American Veterinary Medical Association en
dc.rights American Veterinary Medical Association en
dc.subject Horses en
dc.subject Regional limb perfusion en
dc.subject.lcsh Anti-infective agents in veterinary medicine en
dc.subject.lcsh Horses -- Diseases en
dc.title Clinical use of antimicrobial regional limb perfusion in horses : 174 cases (1999–2009) en
dc.type Article en


Files in this item

This item appears in the following Collection(s)

Show simple item record